Successful Treatment of Transplantation-associated Atypical Hemolytic Uremic Syndrome With Eculizumab-Reference-Cited by-同舟云学术

Successful Treatment of Transplantation-associated Atypical Hemolytic Uremic Syndrome With Eculizumab

Published:2018-01 Issue:1 Volume:40 Page:e41-e44
ISSN:1077-4114
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:

Author:

Hasegawa Daiichiro,Saito Atsuro,Nino Nanako,Uemura Suguru,Takafuji Satoru,Yokoi Takehito,Kozaki Aiko,Ishida Toshiaki,Kawasaki Keiichiro,Yasumi Takahiro,Sakata Naoki,Ohtsuka Yasufumi,Hirase Satoshi,Mori Takeshi,Nishimura Noriyuki,Kusumoto Mayumi,Ogawa Yoshiharu,Tominaga Kenta,Nakagawa Taku,Kanda Kyoko,Tanaka Ryojiro,Kosaka Yoshiyuki

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference14 articles.

1. Thrombotic complications associated with stem cell transplantation;Nadir;Blood Rev,2012

2. Atypical aHUS: state of the art;Nester;Mol Immunol,2015

3. Eculizumab for atypical hemolytic-uremic syndrome;Nürnberger;N Engl J Med,2009

4. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol;Trottestam;Blood,2011

5. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification;Schouten;Nucleic Acids Res,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance;Bone Marrow Transplantation;2023-12-15

2. Clinical features and outcomes of four atypical hemolytic uremic syndrome cases at a single institution in Miyazaki Prefecture from 2015 to 2019;Renal Replacement Therapy;2022-04-11

3. The evaluation of a scoring system for diagnosing atypical hemolytic uremic syndrome;Thrombosis Update;2020-12

4. The Role of Complement in the Pathogenesis of HUS and the TMA Spectrum Disorders;Current Pediatrics Reports;2019-02-13

5. Eculizumab is Efficacious But Often Not Accessible;Journal of Pediatric Hematology/Oncology;2019-01